BALTIMORE, May 29, 2025 /PRNewswire/ -- CraniUS Therapeutics, a cutting-edge medical device company advancing intracranial drug delivery, is proud to announce it has been voted the "2025 Emerging Life ...

BALTIMORE, Jan. 28, 2026 /PRNewswire/ -- CraniUS Therapeutics LLC, a privately held neurotechnology company, today announced it has raised $20 million in Series B financing to accelerate development ...

BALTIMORE, June 29, 2026 /PRNewswire/ -- CraniUS Therapeutics, a neurotechnology company developing a skull-embedded drug delivery platform designed to bypass the blood-brain barrier, today announced ...

The startup, which counts recent Johns Hopkins university alums among its senior-most employees, will put the funds toward developing prototypes of its flagship device for delivering medicine directly ...

BALTIMORE, Nov. 7, 2023 /PRNewswire/ -- CraniUS LLC, an R&D company focused on groundbreaking diagnostics and treatments for patients with chronic brain diseases, has been honored as Company of the ...

BALTIMORE, Feb. 7, 2023 /PRNewswire/ -- CraniUS LLC, an R&D company focused on building groundbreaking diagnostics and treatments for neurosurgical patients with chronic brain disease, announces the ...

The latest patent filing from Cranius LLC describes a reservoir for its implanted drug delivery devices which is shaped and formed to empty and fill reliably without any concern for neighboring organ ...

Recent years have seen progress in treating brain disease, but one major challenge remains: getting therapeutic treatments across the blood-brain barrier. Now, Cranius LLC has raised $19.4 million to ...

CraniUS becomes the first company with a smart, refillable, and fully embedded medical device that effectively bypasses the blood-brain barrier and achieves long-term, convection-enhanced medicine ...

Governor Moore officially launched the Build Our Future program, a $9 million initiative designed to support transformative projects across Maryland’s strategic industry sectors, in 2023 and announced ...

Dr. Henry Brem joins CraniUS Board of Directors in further enhancing its mission to facilitate chronic and direct medicine delivery for treating brain disease. As the Harvey Cushing Professor of ...